Beranda › Fibrosis Paru Idiopatik › Illinois
Uji klinis Fibrosis Paru Idiopatik di Illinois
8 studi untuk Fibrosis Paru Idiopatik mencari peserta di lokasi di Illinois.
Kota di Illinois
Teks studi resmi (Bahasa Inggris)
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Champaign
- Research Site, Chicago
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07652658Pulmonary Fibrosis Foundation Community Registry
- Pulmonary Fibrosis Foundation, Chicago
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05382572RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Christie Clinic on University /ID# 277871, Champaign
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07230288Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Northwestern Medicine, Chicago
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Chicago, Chicago
- Northwestern University, Evanston
- Loyola University Health System, Maywood
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Champaign, IL, Champaign
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06967805A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- University of Chicago, Chicago
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT00470327Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.